Research
ACRE advice: application for a vaccine trial of genetically modified Respiratory Syncytial Virus (24/R56/01)
Published 2024-05-10.
ACRE’s advice on an application from Sanofi Pasteur Inc. to carry out a vaccine trial using genetically modified Respiratory Syncytial Virus.
§ Publishing organisations